Earnings Ahead

GILD - Gilead Sciences Inc

122.62 -2.38 -1.9

Gilead Sciences Inc

Gilead Sciences Inc

About

Profile

At Gilead we are inspired by the opportunity to address unmet medical needs for patients living with life-threatening diseases around the world.


Headquarters

Foster City, California, United States


Intraday

High
-
Low
-

52-week

High
-
Low
-

GILD



 
...

Available for logged in users only.



The multiple price alert feature will smartly add or remove $1 if your alert was hit.
It's only available if you are logged in, a V.I.P. member or if you are using the AI chrome extension.

Contact us via Twitter if you are interested in trying it out.
  • Gilead Sciences Non-GAAP EPS of $1.72 misses by $0.04, revenue of $7.12B beats by $20M
  • Gilead set to roll out Q4 results post-market Tuesday
  • Gilead Sciences stock traded in the red for seventh straight session
  • Earnings week ahead: Alibaba, PepsiCo, Disney, Palantir, McDonalds, Ford and more
  • Arcus Biosciences: Did Gilead Sciences overpay for its latest investment?
  • Gilead gets FDA okay for faster Yescarta production process
  • Arcus shares extend gains amid mixed reactions on Gilead stake purchase
  • Gilead invests $320M in Arcus, expands stake to 33%
  • Big Pharma earnings season in spotlight amid positive sentiment
  • PBMs ramp up lobbying efforts amid growing public scrutiny
  • Gilead stands behind benefits of its CAR-T therapies
  • CAR-T therapies to get boxed warning on blood cancer risk
  • Gilead in selloff after late-stage setback for Trodelvy
  • Biggest stock movers today: Boeing, NuStar Energy, Archer-Daniels-Midland, and more
  • Gilead stock drops as Trodelvy fails Phase 3 lung cancer trial
  • Eli Lilly’s Jaypirca to lead BTK inhibitor market for leukemia
  • Arcus posts early-stage data for Gilead-partnered cancer therapy
  • First RSV shots, groundbreaking gene therapy among 2024 drugs to watch
  • Health stocks to watch this earnings season as sector poised for resurgence
  • Gilead must face negligence claims over HIV drug development, court says
Date Price Open High Low Vol Change
Dec 4 122.62 124.81
124.96
122.4
4.8M -1.9%
Dec 3 125 124.21
125.6
123.88
5.3M 0.88%
Dec 2 123.91 124.4
125.08
123.39
5.1M -0.34%
Dec 1 124.33 125.89
126.23
123.62
5.0M -1.2%
Nov 28 125.84 127.1
127.8
124.9
3.1M -1.31%
 
Nov 26 127.51 126.94
128.16
126.36
5.8M 0.31%
Nov 25 127.12 124.78
127.61
124.7
7.6M 1.48%
Nov 24 125.27 126.96
128.25
124.49
9.6M -1.08%
Nov 21 126.64 125.34
127.98
125.07
10.4M 1.32%
Nov 20 124.99 128.34
128.7
124.54
9.9M -2.4%
Nov 19 128.07 127.09
128.1
125.86
6.9M 0.70%
Nov 18 127.18 124.54
127.36
123.32
8.2M 2.49%
Nov 17 124.09 125.23
126.53
123.91
5.8M -0.74%
Nov 14 125.02 124.81
125.64
122.5
6.6M -0.14%
Nov 13 125.2 123.75
127.68
123.6
9.3M 1.46%
Nov 12 123.4 122.4
124.86
121.8
6.0M 0.69%
Nov 11 122.56 118.61
122.75
118.58
6.3M 3.73%
Nov 10 118.15 119.39
119.85
117.13
7.6M -0.58%
Nov 7 118.84 123.89
124
117.54
9.1M -3.7%
Nov 6 123.4 121.93
124.1
121.72
6.1M 0.67%
Nov 5 122.58 122.2
123.73
121.71
6.4M -0.34%
Nov 4 123 123.15
123.57
119.24
8.5M 0.78%
Nov 3 122.05 119.82
122.32
119.1
8.3M 1.89%
Oct 31 119.79 116.06
121.91
114.02
10.0M 1.14%
Oct 30 118.44 118.8
120.52
117.52
8.3M -0.05%
Oct 29 118.5 117.12
118.96
116.7
6.0M 0.53%
Oct 28 117.88 119.77
120.28
117.79
4.7M -2.15%
Oct 27 120.47 121.49
121.58
119.5
4.8M -0.39%
Oct 24 120.94 120.42
121.14
118.71
5.4M 0.17%
Oct 23 120.74 121.75
121.88
119.45
4.6M -0.59%
Oct 22 121.46 124.24
124.45
121.3
5.4M -2.11%
Oct 21 124.08 123.27
124.61
121.92
5.6M 0.79%
Oct 20 123.11 122.59
123.99
122.2
8.1M 0.24%
Oct 17 122.81 119.64
124.11
119.09
15.8M 4.21%
Oct 16 117.85 117.98
121.57
117.34
6.7M -0.38%
Oct 15 118.3 118.08
119.07
117.07
4.6M -0.15%
Oct 14 118.48 117.51
119.33
116.63
6.3M 0.23%
Oct 13 118.21 116.34
118.78
115.8
5.1M 0.88%
Oct 10 117.18 117.65
119.33
116.5
7.9M 0.38%
Oct 9 116.74 118.75
118.86
116.51
5.0M -1.28%
Oct 8 118.25 117.11
118.35
115.75
6.5M 1.26%
Oct 7 116.78 113.6
116.91
112.82
8.7M 2.82%
Oct 6 113.58 115.67
117
112.41
9.1M 0.79%
Oct 3 112.69 110.74
113.59
109.66
8.1M 1.93%
Oct 2 110.56 110.2
111.7
108.46
10.1M -0.53%
Oct 1 111.15 112
113.07
110.2
13.7M 0.14%
Sep 30 111 113.03
114.86
110.92
10.3M -1.44%
Sep 29 112.62 112.55
112.7
110.82
7.1M 0.46%
Sep 26 112.1 111.35
112.24
110.7
5.1M 1%
Sep 25 110.99 114.52
115.25
110.81
8.4M -2.36%
Sep 24 113.67 114.3
114.57
111.96
5.2M -0.64%
Sep 23 114.4 111.88
115.57
111.75
7.3M 1.70%
Sep 22 112.49 113.45
114.05
112.15
7.3M -1.4%
Sep 19 114.09 114.31
115.07
113.09
12.6M 0.41%
Sep 18 113.62 111.39
113.75
111.26
7.1M 1.21%
Sep 17 112.26 111.37
112.46
111.21
6.5M 1.26%
Sep 16 110.86 113.22
114.13
110.15
5.5M -1.49%
Sep 15 112.54 113.67
113.67
111.32
6.2M -1.75%
Sep 12 114.55 117.49
117.63
114.18
6.5M -2.81%
Sep 11 117.86 115.4
118.11
115.22
5.5M 0%